
News - BPL - Bio Products Laboratory - BPL Group
Bio Products Laboratory (BPL), a leading manufacturer of plasma-derived protein therapies, with US offices in Durham, NC, has been recognized as a Fast 50 company by the Triangle Business Journal for the third year in a row.
BPL Therapeutics - BPL - Bio Products Laboratory - BPL Group
BPL Therapeutics, based in Elstree, UK, houses BPL Group’s headquarters and its manufacturing, quality, R&D, finance and commercial operations. BPL Therapeutics employs over 1,000 people.
BPL Full Year 2021 Results: BPL delivers another strong ... - BPL …
Feb 7, 2022 · Bio Products Laboratory (“BPL”) issues an update on its financial results and operational highlights for the 12 months ended 31 December 2021, including the more recent developments since first half trading update issued in July. BPL is a vertically integrated manufacturer of plasma-derived therapies headquartered in Elstree, UK.
Our Organisation - BPL - Bio Products Laboratory - BPL Group
Kedrion and BPL activities are carried out through a number of companies and subsidiaries.
A commitment for life - BPL - Bio Products Laboratory
Recognising the importance of plasma and with over 60 years of experience in the industry, BPL supplies high-quality plasma-derived medicines to meet the needs of clinicians, patients and customers globally.
Our Values - BPL - Bio Products Laboratory - BPL Group
Unity flourishes when a profound sense of trust permeates among individuals, be they partners, colleagues, or customers. This trust serves as the linchpin for fostering a sharing attitude that unlocks the collective wealth potential within a group and transforms it …
BPL Featured in Manufacturing Today - BPL - BPL Group
Jun 20, 2022 · BPL invests in the latest R&D, technology and manufacturing methods, and continuously adapts to ensure that we continue to serve all our stakeholders effectively. For more information visit http://www.bplgroup.com or https://www.bpl-us.com. BPL consists of two operating divisions — BPL Plasma and BPL Therapeutics.
BPL sells 25 US plasma centres to Grifols for $370 million ... - BPL …
Mar 1, 2021 · Bio Products Laboratory (BPL) announces today the completion of a US$370 million (£265 million) transaction for the sale of 25 of its 51 US-based plasma centres to Biomat USA Inc, a subsidiary of Grifols S.A., a global healthcare company.
Employee experiences - BPL - Bio Products Laboratory - BPL Group
BPL makes no warranties or representations of any kind as to the accuracy, completeness, reliability or usefulness of any information contained in third party sites and shall have no liability for any loss or damage of any kind that may arise from your use of such content or information.
Critical Care - BPL - Bio Products Laboratory - BPL Group
BPL makes no warranties or representations of any kind as to the accuracy, completeness, reliability or usefulness of any information contained in third party sites and shall have no liability for any loss or damage of any kind that may arise from your use of such content or information.